1. Market Research
  2. > Pathology Industry

Bladder Cancer Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Molecular Diagnostic, Clinical Trial, Biomarker, Cancer Diagnostic, Diagnostic, Oncology, Therapeutics.


 
1-10 of 32 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

Global Bladder Cancer Partnering 2010 to 2016

Global Bladder Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development ...

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Global Bladder Cancer Therapeutics Industry 2015 Market Research Report

Global Bladder Cancer Therapeutics Industry 2015 Market Research Report

  • $ 2 800
  • Industry report
  • November 2015
  • by QY Research Group

Summary The Global Bladder Cancer Therapeutics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Bladder Cancer Therapeutics industry. The report provides ...

North America Bladder Cancer Therapeutics Industry 2015 Market Research Report

North America Bladder Cancer Therapeutics Industry 2015 Market Research Report

  • $ 3 800
  • Industry report
  • November 2015
  • by QY Research Group

Summary The North America Bladder Cancer Therapeutics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Bladder Cancer Therapeutics industry. The report ...

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • October 2015
  • by Global Markets Direct

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladde ...

Bladder Cancer Treatment Drugs Companies in China

Bladder Cancer Treatment Drugs Companies in China

  • $ 1 800
  • Industry report
  • October 2015
  • by Asia Market Information & Development Company

This study focuses on China’s Bladder Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

The 2016-2021 Outlook for Bladder Cancer Therapeutics in the United States

The 2016-2021 Outlook for Bladder Cancer Therapeutics in the United States

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for bladder cancer therapeutics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ...

The 2016-2021 Outlook for Bladder Cancer Therapeutics in India

The 2016-2021 Outlook for Bladder Cancer Therapeutics in India

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for bladder cancer therapeutics across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

About 1 100 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • February 2015
    75 pages
  • Bladder Cancer  

    Cancer  

    Oncology  

  • United Kingdom  

    Europe  

View report >

Pathology Description

January 2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.